how to semaglutide work GLP-1 for Medical Weight Loss Semaglutide Vs Tirzepatide For Weight

Theres often very little follow-up, minimal education around behavior change, and not much focus on body composition or long-term metabolic health, says Class

Primary candidates for GLP-1 therapy include: Patients with type 2 diabetes and inadequate glycemic control despite metformin therapy Individuals with type 2 diabetes and established atherosclerotic cardiovascular disease Patients with type 2 diabetes and multiple cardiovascular risk factors (hypertension, dyslipidemia, obesity) Adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with weight-related comorbidities Patients with metabolic syndrome who have not achieved adequate risk factor control with lifestyle modification For patients with dyslipidemia, GLP-1 agents may be particularly valuable when combined with statin therapy in those who have not reached LDL-C goals or who have persistent hypertriglyceridemia despite statin treatment

Journal of Clinical Endocrinology & Metabolism, 100 (3), 1096-1103

Instead of following the standard titration schedule, microdosing involves starting at sub-therapeutic doses, often 0.5mg to 1.25mg, and increasing in very small increments